
Combines a DPP-4 inhibitor with extended-release Metformin. It improves insulin response and reduces glucose production in the liver. Suitable for patients whose sugar is not controlled with a single drug.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Novalab Healthcare Pvt. Ltd. is an ISO-certified and WHO-GMP-compliant pharmaceutical company headquartered in Panchkula, Haryana, India, established around 2014.
Key Details
• Core Business: Offers PCD Pharma Franchise and third-party/contract manufacturing services across India.
• Leadership: Directed by CEO Mr. Pankaj Aggarwal / Agrawal.
• Product Range: Over 1,000 to 2,000 formulations spanning cardiac, diabetic, dermatology, pediatrics, gynecology, ophthalmology, critical care, Ayurvedic/herbal ranges, injectables, syrups, and protein powders.
• Services: Provides monopoly-based PCD franchise rights, marketing support, and nationwide distribution.
• Official Website: You can find more information on the Novalab Healthcare Official Website.
If you are looking for specific details—such as their product catalog, franchise terms, or contact information—let me know and I can help you find them.